Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-09

Clinical Trial Update: Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial assessing fluocinonide cream to relieve vaginal dryness and painful intercourse in breast cancer patients undergoing hormone therapy; results have…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluocinonide Cream (fluocinonide)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Breast Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2017-08-09